Gelesis Holdings, Inc.
GLS
Rank in Stocks
#40624
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing... Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream. The company also provides an additional product for individuals who are overweight or obese, and its robust pipeline features potential treatments for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Established in 2006, Gelesis Holdings Inc. operates from its headquarters in Boston, Massachusetts.
Share Price
$0.0121
Last synced: 2023-05-23
Market Cap
$97.54K
Change (1 day)
-24.38%
Change (1 year)
12,000.00%
Country
US
Trade Gelesis Holdings, Inc. (GLS)
Category
Healthcare
Stock split history for Gelesis Holdings, Inc. (GLS)
Gelesis Holdings, Inc. stock (symbol: GLS) underwent a total of 0 stock splits.
The most recent stock split occurred on Oct 20, 2026.
One GLS share bought prior to Oct 20, 2026 would equal to 0 GLS shares today.
The most recent stock split occurred on Oct 20, 2026.
One GLS share bought prior to Oct 20, 2026 would equal to 0 GLS shares today.
Stock split list
| Year | Split | Multiple | Cumulative Multiple |
|---|---|---|---|
| Not enough data for the provided dates. | |||
Stock splits for similar companies or competitors
| Company | Number of stock splits | Cumulative Multiple | Country |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
